08:00 , Dec 13, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Metabolic disease; obesity Phosphoenolpyruvate carboxykinase 1 (PCK1) A zebrafish screening study identified metabolic activators that could...
02:39 , Feb 28, 2007 |  BC Extra  |  Clinical News

Celera finds genetic links to AD

Researchers from CRA reported in Human Molecular Genetics that they identified several candidate genetic markers associated with late-onset Alzheimer's disease (AD). They reported 19 SNPs that showed significant association with late-onset AD. Some of...